Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Stem Cell Reports
|
October 31, 2025
Activation of canonical Wnt signaling is required for efficient direct reprogramming into human hepatic progenitor cells
Shizuka Miura, Kenichi Horisawa, Hiroki Inada, et al.
Journal of Gastroenterology
|
February 5, 2024
A novel, small anti-HBV compound reduces HBsAg and HBV-DNA by destabilizing HBV-RNA
Takehisa Watanabe, Sanae Hayashi, Yan Zhaoyu, et al.
International Journal of Clinical Oncology
|
September 19, 2024
Clinical utility of a comprehensive genomic profiling test for patient with advanced biliary tract cancer
Hiroki Inada, Hideaki Miyamoto, Satoru Shinriki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
May 3, 2025
Serum alpha-fetoprotein/hepatocyte growth factor ratio as a novel biomarker predicting the prognosis of acute alcoholic hepatitis
Hiroki Inada, Katsuya Nagaoka, Kenyu Hashimoto, et al.
World Journal of Clinical Cases
|
January 4, 2021
Risk factors for <i>de novo</i> hepatitis B during solid cancer treatment
Rie Sugimoto, Masayuki Furukawa, Takeshi Senju, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
October 9, 2021
Optimal management of lenvatinib therapy for patients with unresectable hepatocellular carcinoma by balancing the therapeutic effect with the relative dose intensity
Takayuki Tokunaga, Masakuni Tateyama, Kentaro Tanaka, et al.
Journal of Gastroenterology
|
November 17, 2025
TP53 mutation predicts resistance to immune checkpoint inhibitor-based therapy in intrahepatic cholangiocarcinoma
Hiroki Inada, Sotaro Kurano, Hideaki Miyamoto, et al.
Cancers
|
March 11, 2023
Therapeutic Modifications without Discontinuation of Atezolizumab Plus Bevacizumab Therapy Are Associated with Favorable Overall Survival and Time to Progression in Patients with Unresectable Hepatocellular Carcinoma
Takayuki Tokunaga, Masakuni Tateyama, Yasuteru Kondo, et al.
Clinical Journal of Gastroenterology
|
June 27, 2021
Improved indocyanine green retention after short-term lenvatinib withdrawal in three patients with hepatocellular carcinoma
Rie Sugimoto, Hiroki Inada, Yuki Tanaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
November 29, 2023
Randomized phase I/II study of vascular endothelial growth factor receptor peptide vaccines for patients with hepatocellular carcinoma
Yoko Yoshimaru, Katsuya Nagaoka, Kentaro Tanaka, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Stem Cell Reports
|
October 31, 2025
Activation of canonical Wnt signaling is required for efficient direct reprogramming into human hepatic progenitor cells
Shizuka Miura, Kenichi Horisawa, Hiroki Inada, et al.
Journal of Gastroenterology
|
February 5, 2024
A novel, small anti-HBV compound reduces HBsAg and HBV-DNA by destabilizing HBV-RNA
Takehisa Watanabe, Sanae Hayashi, Yan Zhaoyu, et al.
International Journal of Clinical Oncology
|
September 19, 2024
Clinical utility of a comprehensive genomic profiling test for patient with advanced biliary tract cancer
Hiroki Inada, Hideaki Miyamoto, Satoru Shinriki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
May 3, 2025
Serum alpha-fetoprotein/hepatocyte growth factor ratio as a novel biomarker predicting the prognosis of acute alcoholic hepatitis
Hiroki Inada, Katsuya Nagaoka, Kenyu Hashimoto, et al.
World Journal of Clinical Cases
|
January 4, 2021
Risk factors for <i>de novo</i> hepatitis B during solid cancer treatment
Rie Sugimoto, Masayuki Furukawa, Takeshi Senju, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
October 9, 2021
Optimal management of lenvatinib therapy for patients with unresectable hepatocellular carcinoma by balancing the therapeutic effect with the relative dose intensity
Takayuki Tokunaga, Masakuni Tateyama, Kentaro Tanaka, et al.
Journal of Gastroenterology
|
November 17, 2025
TP53 mutation predicts resistance to immune checkpoint inhibitor-based therapy in intrahepatic cholangiocarcinoma
Hiroki Inada, Sotaro Kurano, Hideaki Miyamoto, et al.
Cancers
|
March 11, 2023
Therapeutic Modifications without Discontinuation of Atezolizumab Plus Bevacizumab Therapy Are Associated with Favorable Overall Survival and Time to Progression in Patients with Unresectable Hepatocellular Carcinoma
Takayuki Tokunaga, Masakuni Tateyama, Yasuteru Kondo, et al.
Clinical Journal of Gastroenterology
|
June 27, 2021
Improved indocyanine green retention after short-term lenvatinib withdrawal in three patients with hepatocellular carcinoma
Rie Sugimoto, Hiroki Inada, Yuki Tanaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
November 29, 2023
Randomized phase I/II study of vascular endothelial growth factor receptor peptide vaccines for patients with hepatocellular carcinoma
Yoko Yoshimaru, Katsuya Nagaoka, Kentaro Tanaka, et al.
Page
of 2